Investors
Information Disclosure
-
VOLUNTARY ANNOUNCEMENT - SHARE PURCHASE PURSUANT TO RESTRICTED SHARE AWARD SCHEME2021.12.29
-
VOLUNTARY ANNOUNCEMENT - INNOVATIVE MEDICINE "TCR1672" OBTAINED APPROVAL FOR CLINICAL TRIAL2021.12.21
-
VOLUNTARY ANNOUNCEMENT - EXCLUSIVE SALES AGREEMENT OF PENPULIMAB MONOCLONAL ANTIBODY2021.12.20
-
VOLUNTARY ANNOUNCEMENT - SHARE PURCHASE PURSUANT TO RESTRICTED SHARE AWARD SCHEME2021.12.07
-
Monthly Return of Equity Issuer on Movements in Securities for the Month Ended 30 November 20212021.12.06
-
ANNOUNCEMENT PURSUANT TO RULE 13.18 OF THE LISTING RULES - FACILITY AGREEMENT WITH SPECIFIC PERFORMANCE COVENANTS2021.12.01
-
VOLUNTARY ANNOUNCEMENT - SHARE PURCHASE PURSUANT TO RESTRICTED SHARE AWARD SCHEME2021.11.08
-
Monthly Return of Equity Issuer on Movements in Securities for the Month Ended 31 October 20212021.11.01